Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Colleague Insights
Grand Rounds
Conferences
Video Expert Opinion
Living Resources
Sign in
Join now
Deborah Wexler MD, MSc
Deborah J. Wexler MD, MSc Associate Editor
Richard Pratley MD
Richard E. Pratley MD Associate Editor
Kathleen Dungan MD, MPH
Kathleen M. Dungan MD, MPH Advisory Board
See All Experts
featured
Published in Diabetes and
1 other channel

Journal Scan / Research · December 18, 2024

Weight Changes After Treatment With Semaglutide in Individuals With MASLD/MASH With or Without Type 2 Diabetes

Diabetes, Obesity & Metabolism

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Carolina Gonzalez-Lopez MD

Diabetes, Obesity & Metabolism
Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction-associated steatotic liver disease: Post hoc analysis of three randomised controlled trials
Diabetes Obes Metab 2024 Nov 28;[EPub Ahead of Print], MJ Armstrong, T Okanoue, M Sundby Palle, AS Sejling, M Tawfik, M Roden

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated